Longeveron, Inc. (LGVN)
0.7799
+0.03
(+3.44%)
USD |
NASDAQ |
Jun 09, 16:00
0.7799
0.00 (0.00%)
After-Hours: 19:30
Longeveron Total Assets (Quarterly) : 21.21M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| HCW Biologics Inc. | 27.34M |
| Arrowhead Pharmaceuticals, Inc. | 2.268B |
| Oncolytics Biotech, Inc. | 8.161M |
| Sangamo Therapeutics, Inc. | 59.96M |
| Sarepta Therapeutics, Inc. | 3.179B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 5.183M |
| Shareholders Equity (Quarterly) | 16.03M |
| Debt to Equity Ratio | 0.0467 |
| Current Ratio | 3.879 |
| Net Debt Paydown Yield | 0.44% |